| نویسندگان | پرستو عارضی,زهرا رضوانی |
| همایش | International Tehran Breast Cancer Congress |
| تاریخ برگزاری همایش | 2015-10-28 |
| محل برگزاری همایش | تهران |
| نوع ارائه | سخنرانی |
| سطح همایش | بین المللی |
چکیده مقاله
Introduction: Protein kinase D is a family of serine/threonine kinase superfamily.
Three mammalian genes encode three different isoform of PKD. The different
between them related to their domains, contains catalytic domain, binding domain
C1 and pleckstrin homology domain. PKD play important role in many cellular
processes, for example basic signaling mechanisms, stress oxidative, angiogenesis
and recently demonstrate that directly negative effect on cell migration and
invasion on tumor cells.
Material and Methods: now a day abnormal expression of PKD is observe in many
cancer cell, such as pancreatic, gastric, lymphoma, etc. In this review we focused on
PKD changes in breast cancer.
Results: in the highly invasive cell lines same as SKBR3, T47D observed little or no
PKD1 express, while in very low invasive breast cancer cell lines such as MCF-7
and BT-474 moderate expression of PKD1 was observed. New study determined
that low level of PKD1 expression in highly invasive lines related to epigenetic
silencing by DNA methylation. Also suggest that role of PKD1 in cancerous cells
may relate with matrix metalloproteinase (MMP), because PKD1 act as a negative
regulator of MMP expression. Another critical function of PKD1 phosphorylation of
SSH1L, so has a negative effect on cell migration.
Conclusion: finally determined that decreased PKD expression can act as a marker
in metastatic breast cancer. And since PKD suppress metastasis of breast cancer
today regulate of PKD is one of the important goals in the treatment of breast
cancer.